Loading...
Search Filters
Date Range
toReport Types
Condition
See all (6)
Region of the Body
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Showing 1 - 11 of 11
Alendronate is superior to alfacalcidol in preventing glucocorticoid-induced bone loss
N Engl J Med. 2006 Aug 17;355(7):675-84
Effectiveness of Alendronate versus Alfacalcidol in maintaining bone mineral density
Journal of Bone and Joint Surgery American; 2011; 93(A); 1203-1209
Eldecalcitol reduces risk of vertebral fractures in osteoporotic patients
Bone. 2011 Oct;49(4):605-12. doi: 10.1016/j.bone.2011.07.011. Epub 2011 Jul 19
Network meta-analysis of current drug options for the treatment of osteoporosis in men
PLoS One. 2015 May 26;10(5):e0128032
Strontium ranelate and alfa D3 improve outcomes of postmenopausal osteoporosis
Drugs R D. 2014 Dec;14(4):315-24.
Alendronate is an effective way of increasing BMD and reducing bone turnover
J Int Med Res. 2011;39(1):302-10
Etidronate, alendronate, and reisendronate significantly reduce the risk of hip fracture
Curr Med Res Opin. 2011 Jun;27(6):1141-8. doi: 10.1185/03007995.2011.570747. Epub 2011 Apr 1
The role of alendronate in osteoporosis patients undergoing PLIF
J Neurosurg Spine. 2011 Apr;14(4):500-7. doi: 10.3171/2010.11.SPINE10245. Epub 2011 Jan 28
Bisphosphates to prevent femoral periprosthetic bone resorption after cementless THA
J Orthop Surg Res. 2015 May 13;10(1):65
Showing 1 - 11 of 11